Overview of the Mutational Landscape in Primary Myelofibrosis and Advances in Novel Therapeutics

Primary Myelofibrosis is a BCR-ABL negative myeloproliferative neoplasm with a variety of hematological presentations, including thrombosis, bleeding diathesis and marrow fibrosis. It is estimated to have an incidence of 1.5 per 100,000 people each year. Although JAK2 or MPL mutations are seen in PM...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilani, Jaleed Ahmed, Ashfaq, Muhammad Areeb, Armaghan-e-Rehman, Armaghan-e-Rehman, Jabbar, Adnan Abdul, Siddiqui, Tariq, Khan, Maliha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021616/
https://www.ncbi.nlm.nih.gov/pubmed/31244289
http://dx.doi.org/10.31557/APJCP.2019.20.6.1691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021616/
https://www.ncbi.nlm.nih.gov/pubmed/31244289
http://dx.doi.org/10.31557/APJCP.2019.20.6.1691

Ejemplares similares